Artificial Intelligence & ALS: Identifying Drug Candidates for A Cure

To date, FDA has approved only four drugs for the treatment of ALS, including just one drug, Riluzole, that has actually been found to prolong the survival of ALS patients.

Today’s advanced technology and informatics are offering a new sense of hope, however, for determining potential ALS disease-causing pathways and therefore offering better drug candidates for the estimated 12,000 to 15,000 people in the U.S. and 700,000 people worldwide who have been diagnosed with the condition.